CN106236904A - A kind of Chinese medicine treating cystic polyp - Google Patents
A kind of Chinese medicine treating cystic polyp Download PDFInfo
- Publication number
- CN106236904A CN106236904A CN201610735479.2A CN201610735479A CN106236904A CN 106236904 A CN106236904 A CN 106236904A CN 201610735479 A CN201610735479 A CN 201610735479A CN 106236904 A CN106236904 A CN 106236904A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- polyp
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine treating cystic polyp, medicine including following parts by weight is prepared from: the Fructus Phyllanthi of 20 30 parts by weight, the Radix Phytolaccae of 15 25 parts by weight, the Lignum Dalbergiae Odoriferae of 20 30 parts by weight, the Rhizoma Chuanxiong of 15 25 parts by weight, the Semen Strychni of 37 parts by weight, the Herba Houttuyniae of 25 35 parts by weight, the Radix Glycyrrhizae of 5 10 parts by weight.The present invention forms with pure traditional Chinese medicine, and scientific formulation is reasonable, and configuration is simple, having no side effect, curative effect is short, instant effect, it is different from the Therapeutic Principle in the past treating cystic polyp, there is effect of promoting flow of QI and blood, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, invigorating the spleen and replenishing QI, wind-expelling pain-stopping.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine treating cystic polyp.
Background technology
Cystic polyp refer to gallbladder wall to the general name that intracavity is the raised class pathological changes of polypoid, also known as " gallbladder protuberance property
Pathological changes ".The cystic polyp of indication includes by the mucosa polypoid proliferation caused by gallbladder inflammation, gallbladder mucosa cell clinically
Polypoid change, Gallbladder adenormal polypi and polypoid carcinoma of gallbladder etc. caused by degeneration.Cystic polyp has good on pathology
Property polyp and malignant polyp point.Optimum cystic polyp is divided into benign tumor polyp and the big class of pseudotumor polyp two, Qi Zhongliang
Property tumprigenicity polyp can derive from epithelial tissue (adenoma) and supporting tissue (hemangioma, lipoma etc.), and pseudotumor polyp is then
Including cholesterol polyp, inflammatory polyp, sick, the tissue heterotopic polyp of adenomyoma of gallbladder etc..Gallbladder adenormal polypi is potential
Precancerous lesion, the generation with carcinoma of gallbladder is relevant.In contrast to this, pseudotumor polyp such as cholesterol polyp, inflammatory polyp and gallbladder
Capsule adenomyoma then will not occur canceration.
The method for the treatment of cystic polyp is mainly based on excision at present, but excision does not only exist certain wind
Danger, and very big to human injury, gallbladder removal can be caused the resentment of patient；And treat the Chinese medicine of cystic polyp at present
Therapeutic effect is the best, and in its prescription, the Chinese medicine of dynamic then tens taste twenties tastes, has seemed good curative effect, this big prescription
The financial burden of the patient that on the one hand medicine increases the weight of, it is often more important that the use of big prescription medicine has increased the weight of between prescription Chinese medicine
Toxic and side effects, not only do not have what due curative effect, also can bring unnecessary potential safety hazard to patient.
Summary of the invention
For the deficiencies in the prior art, the present invention provides a kind of low cost, instant effect, and cure rate is high, has no side effect
The Chinese medicine for the treatment of cystic polyp.
The technical scheme is that and be achieved in that: a kind of Chinese medicine treating cystic polyp, including following parts by weight
Raw material of Chinese medicine is prepared from: the Fructus Phyllanthi of 20-30 parts by weight, the Radix Phytolaccae of 15-25 parts by weight, the fall of 20-30 parts by weight
Perfume (or spice), the Rhizoma Chuanxiong of 15-25 parts by weight, the Semen Strychni of 3-7 parts by weight, the Herba Houttuyniae of 25-35 parts by weight, 5-10 parts by weight
Radix Glycyrrhizae.
Technical scheme can be achieved in that
A kind of Chinese medicine treating cystic polyp, the medicine including following parts by weight is prepared from: 25 parts by weight remaining
Gan Zi, the Radix Phytolaccae of 20 parts by weight, the Lignum Dalbergiae Odoriferae of 25 parts by weight, the Rhizoma Chuanxiong of 20 parts by weight, the Semen Strychni of 5 parts by weight, 30
The Herba Houttuyniae of parts by weight, the Radix Glycyrrhizae of 6 parts by weight.
Each raw material is mixed by the present invention, is ground into fine powder, directly takes, and three times a day, each 2-3 gram, warm water takes.
The course for the treatment of: 3 days be a course for the treatment of, the 1-5 course for the treatment of need to be taken.
The pharmacology of each concrete ingredient is as follows:
Fructus Phyllanthi: sweet, sour, puckery, cool；Clearing away heat and cooling blood, promoting digestion and invigorating the stomach, cough-relieving of promoting the production of body fluid.
Radix Phytolaccae: bitter, cold is poisonous；Relieve oedema or abdominal distension through diuresis or purgation detumescence, smoothening secretion, detoxicating and resolving stagnation of pathogens.
Lignum Dalbergiae Odoriferae: pungent, temperature；Promoting flow of QI and blood, pain relieving, hemostasis.
Rhizoma Chuanxiong: pungent, temperature；Blood-activating and qi-promoting, wind-expelling pain-stopping.
Semen Strychni: bitter, warm, very toxic；Removing obstruction in the collateral to relieve pain, mass dissipating and swelling eliminating.
Herba Houttuyniae: pungent, is slightly cold；Heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome.
Radix Glycyrrhizae: sweet, flat；Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The function of the present invention and curing mainly: Rhizoma Chuanxiong, Lignum Dalbergiae Odoriferae promoting flow of QI and blood in the present invention；Fructus Phyllanthi, Radix Phytolaccae, Herba Houttuyniae, Radix Glycyrrhizae
Heat-clearing and toxic substances removing；Radix Phytolaccae, Semen Strychni dispersing swelling and dissipating binds；Lignum Dalbergiae Odoriferae, Rhizoma Chuanxiong, Semen Strychni, Radix Glycyrrhizae invigorating the spleen and replenishing QI, wind-expelling pain-stopping, all medicines are played altogether
Promoting flow of QI and blood, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, invigorating the spleen and replenishing QI, effect of wind-expelling pain-stopping.
Beneficial effects of the present invention: the present invention forms with pure traditional Chinese medicine, scientific formulation is reasonable, and configuration is simple, nontoxic pair
Effect, curative effect is short, instant effect, is different from the Therapeutic Principle in the past treating cystic polyp, has promoting flow of QI and blood, heat-clearing and toxic substances removing, disappears
Swollen eliminating stagnation, invigorating the spleen and replenishing QI, effect of wind-expelling pain-stopping.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine treating cystic polyp, the medicine including following weight grams is prepared from: 20 grams
Fructus Phyllanthi, the Radix Phytolaccae of 15 grams, the Lignum Dalbergiae Odoriferae of 20 grams, the Rhizoma Chuanxiong of 15 grams, the Semen Strychni of 3 grams, the Herba Houttuyniae of 25 grams, the Radix Glycyrrhizae of 5 grams.
Embodiment 2: a kind of Chinese medicine treating cystic polyp, the medicine including following weight grams is prepared from: 30 grams
Fructus Phyllanthi, the Radix Phytolaccae of 25 grams, the Lignum Dalbergiae Odoriferae of 30 grams, the Rhizoma Chuanxiong of 25 grams, the Semen Strychni of 7 grams, the Herba Houttuyniae of 35 grams, the Radix Glycyrrhizae of 10 grams.
Embodiment 3: a kind of Chinese medicine treating cystic polyp, the medicine including following weight grams is prepared from: 25 grams
Fructus Phyllanthi, the Radix Phytolaccae of 20 grams, the Lignum Dalbergiae Odoriferae of 25 grams, the Rhizoma Chuanxiong of 20 grams, the Semen Strychni of 5 grams, the Herba Houttuyniae of 30 grams, the Radix Glycyrrhizae of 6 grams.
Embodiment 4: a kind of Chinese medicine treating cystic polyp, the medicine including following weight grams is prepared from: 21 grams
Fructus Phyllanthi, the Radix Phytolaccae of 17 grams, the Lignum Dalbergiae Odoriferae of 26 grams, the Rhizoma Chuanxiong of 22 grams, the Semen Strychni of 4 grams, the Herba Houttuyniae of 32 grams, the Radix Glycyrrhizae of 7 grams.
Each raw material is mixed by Chinese medicine in embodiment 1-4 in the preparation, is ground into fine powder, directly takes, three times a day, often
Secondary 2-3 gram, take with warm water.
The present invention is not limited to above-mentioned preferred forms, anyone draw under the enlightenment of the present invention other any with
Product as the present invention is same or like, within all falling within protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
Effective cure rate statistics of the Chinese medicine of the present invention, criterion of therapeutical effect is as follows:
Cure: disease, sign are recovered completely；
Effective: disease, sign make moderate progress；
Invalid: disease, sign are without any improvement.
The present invention treats patient's totally 39 example participating in statistics, wherein: 31 examples of fully recovering, effective 6 examples, invalid 2 examples, total effective rate
Reach 94%.
Model case:
Hu, man, 39 years old, cystic polyp diameter 7mm, by here Drug therapy, fully recovers after three days.
Zhu, female, 48 years old, stomachache, abdominal distention, cystic polyp diameter 12mm, by here Drug therapy, fully recovers after one week.
Liu, man, 47 years old, intermittent right epigastric discomfort, with cholelithiasis, treat by here, fully recover after two weeks.
Claims (2)
1. the Chinese medicine treating cystic polyp, it is characterised in that: include that the medicine of following parts by weight is prepared from: 20-30
The Fructus Phyllanthi of parts by weight, the Radix Phytolaccae of 15-25 parts by weight, the Lignum Dalbergiae Odoriferae of 20-30 parts by weight, the Rhizoma Chuanxiong of 15-25 parts by weight,
The Semen Strychni of 3-7 parts by weight, the Herba Houttuyniae of 25-35 parts by weight, the Radix Glycyrrhizae of 5-10 parts by weight.
A kind of Chinese medicine treating cystic polyp the most according to claim 1, it is characterised in that: include following parts by weight
Medicine is prepared from: the Fructus Phyllanthi of 25 parts by weight, the Radix Phytolaccae of 20 parts by weight, the Lignum Dalbergiae Odoriferae of 25 parts by weight, 20 parts by weight
Rhizoma Chuanxiong, the Semen Strychni of 5 parts by weight, the Herba Houttuyniae of 30 parts by weight, the Radix Glycyrrhizae of 6 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610735479.2A CN106236904A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating cystic polyp |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610735479.2A CN106236904A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating cystic polyp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106236904A true CN106236904A (en) | 2016-12-21 |
Family
ID=57596589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610735479.2A Withdrawn CN106236904A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating cystic polyp |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106236904A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107693698A (en) * | 2017-10-30 | 2018-02-16 | 张泽钧 | A kind of Chinese medicine for treating gallbladder polyps |
-
2016
- 2016-08-26 CN CN201610735479.2A patent/CN106236904A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107693698A (en) * | 2017-10-30 | 2018-02-16 | 张泽钧 | A kind of Chinese medicine for treating gallbladder polyps |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110393781B (en) | Pure traditional Chinese medicine preparation for treating thyroid nodule and preparation method thereof | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN102885997B (en) | Traditional Chinese medicine for treating neurodermatitis | |
| CN102727695B (en) | Traditional Chinese medicine for treating hemafecia | |
| CN106236904A (en) | A kind of Chinese medicine treating cystic polyp | |
| CN104147554A (en) | Traditional Chinese medicine for treating cancer pain | |
| CN109248286A (en) | A kind of drug and preparation method thereof for treating lymph cancer | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN103860823A (en) | External pain-stopping tincture for cancer | |
| CN107468870A (en) | It is a kind of to be used to treat ointment medicine of dermatitis and preparation method thereof | |
| CN103893348B (en) | A kind of Chinese medicine ointment for the treatment of radioactive skin injury and preparation method | |
| CN104887823A (en) | Traditional Chinese medicine composition for treating nasopharyngeal carcinoma and administration method thereof | |
| CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN104606447A (en) | Traditional Chinese medicine preparation for treating exogenous fever | |
| CN105412244A (en) | Traditional Chinese medicine composition treating gynecological cervicitis | |
| CN103961408A (en) | Traditional Chinese medicine for treating haemorrhoids | |
| CN105079071A (en) | Instant anodyne for treating advanced esophageal carcinoma and preparation method of the instant anodyne | |
| CN104096037A (en) | Traditional Chinese medicine capsule for treating breast hyperplasia | |
| CN103977124A (en) | Chinese herbal preparation for treating urinary stone | |
| CN103585607B (en) | Traditional Chinese medicine for treating facial paralysis | |
| CN104083541A (en) | Traditional Chinese medicament for treating furunculosis | |
| CN104189815A (en) | Traditional Chinese medicine preparation for treating children bronchial asthma | |
| CN103977181A (en) | Medicine for treating thyrophyma and preparation method | |
| CN115282247A (en) | Traditional Chinese medicine for treating advanced cancer and preparation method thereof | |
| CN112402577A (en) | Traditional Chinese medicine composition for liver space occupying venereal disease and interventional operation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161221 |
|
| WW01 | Invention patent application withdrawn after publication |